Fatal hemorrhagic diathesis associated with mild factor IX deficiency in PL/J mice

Comparative Medicine

Volumn 56, Issue 5, 2006, Pages 426-434

  Trammell, Rita A ^a   Brooks, Marjory ^e   Cox, Lisa ^a   Ding, Ming ^a   Wagenknecht, Dawn R ^b   Rehg, Jerold E ^d   McIntyre, John A ^b,c   Toth, Linda A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Francis Hospital   (United States)

^c INDIANA UNIVERSITY   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HIGH MOLECULAR WEIGHT KININOGEN; PREKALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING; HUMAN; IMPLANTATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PLASMA; SURGICAL INSTRUMENT; TREATMENT PLANNING;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FACTOR IX; HEMOPHILIA B; HEMORRHAGIC DISORDERS; IMMUNOGLOBULIN ISOTYPES; IMPLANTS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; POSTOPERATIVE COMPLICATIONS;

EID: 33750046889     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Al Hajjaj MS. 2000. Massive pulmonary hemorrhage in a Saudi female with primary antiphospholipid syndrome. Saudi Med J 21:777-779.
2. Allen RC, Meier H, Hoag WG. 1962. Ethylene glycol produced by ethylene oxide sterilization and its effect on blood-clotting factors in an inbred strain of mice. Nature 193:387-388.
3. Asherson RA, Cervera R, Wells AU. 2005. Diffuse alveolar hemorrhage: a nonthrombotic antiphospholipid lung syndrome? Semin Arthritis Rheum 35:138-142.
4. Attali O, Vinciguerra C, Trzeciak MC, Durin A, Pernod G, Gay V, Menart C, Sobas F, Dechavanne M, Negrier C. 1999. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations. Thromb Haemost 82:1437-1442.
5. Biggs R, Douglas AS, MacFarlane RG, Dacie JV, Pitney WR, Merskey. 1952. Christmas disease: a condition previously mistaken for haemophilia. Br Med J 2:1378-1382.
6. Bolton-Maggs PH, Pasi KJ. 2003. Haemophilias A and B. Lancet 361:1801-1809.
7. Bowen DJ. 2002. Haemophilia A and haemophilia B: molecular insights. Mol Pathol 55:127-144.
8. Brooks MB, Gu W, Barnas JL, Ray J, Ray K. 2003. A Line 1 insertion in the factor IX gene segregates with mild hemophilia B in dogs. Mamm Genome 14:788-795.
9. Carr ME Jr, Martin EJ. 2004. Evolving techniques for monitoring clotting in plasma and whole blood samples. Clin Lab 50:539-549.
10. Chavakis T, Boeckel N, Santoso S, Voss R, Isordia-Salas I, Pixley RA, Morgenstern E, Colman RW, Preissner KT. 2002. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular-weight kininogen. J Biol Chem 277:23157-23164.
11. Chavakis T, Kanse SM, Pixley RA, May AE, Isordia-Salas I, Colman RW, Preissner KT. 2001. Regulation of leukocyte recruitment by polypeptides derived from high molecular-weight kininogen. FASEB J 15:2365-2376.
12. Chavakis T, Pixley RA, Isordia-Salas I, Colman RW, Preissner KT. 2002. A novel antithrombotic role for high molecular-weight kininogen as inhibitor of plasminogen activator inhibitor-1 function. J Biol Chem 277:32677-32682.
13. Chavakis T, Preissner KT. 2003. Potential pharmacological applications of the antithrombotic molecule high molecula-weight kininogen. Curr Vasc Pharmacol 1:59-64.
14. Chavakis T, Santoso S, Clemetson KJ, Sachs UJ, Isordia-Salas I, Pixley RA, Nawroth PP, Colman RW, Preissner KT. 2003. High molecular-weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib. J Biol Chem 278:45375-45381.
15. Colman RW, White JV, Scovell S, Stadnicki A, Sartor RB. 1999. Kininogens are antithrombotic proteins in vivo. Arterioscler Thromb Vasc Biol 19:2245-2250.
16. Dellalibera-Joviliano R, Dos Reis ML, Cunha FQ, Donadi EA. 2003. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus. J Rheumatol 30:485-492.
17. Drews RE. 2003. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 24:607-622.
18. Entrez Gene Database [Internet]. National Center for Biotechnology Information. [Cited 2006 August 30]. Available from: http://www. ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucleotide&val=94407752.
19. Espinola RG, Uknis A, Sainz IM, Isordia-Salas I, Pixley R, DeLa CR, Long W, Agelan A, Gaughan J, Adam A, Colman RW. 2004. A monoclonal antibody to high molecular-weight kininogen is therapeutic in a rodent model of reactive arthritis. Am J Pathol 165:969-976.
20. Gallimore MJ, Harris SL, Jones DW, Winter M. 2004. Plasma levels of factor XII, prekallikrein and high molecular-weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res 114:91-96.
21. Garcia CO, Kanbour-Shakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE. 1997. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol 37:118-124.
22. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden-Stanfield M, Harris EN. 2002. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 46:545-552.
23. Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG. 1998. Haemophilia B: database of point mutations and short additions and deletions-eighth edition. Nucleic Acids Res 26:265-268.
24. Haemophilia B Mutation Database [Internet]. London: King's College London, University of London. [cited 2006 April 10]. Available from: http://www.kcl.ac.uk/ip/petergreen/haemBdatabase. html.
25. Hall JM. 1997. Bradykinin receptors. Gen Pharmacol 28:1-6.
26. Hematological Research: clotting defects Database [Internet]. The Jackson Laboratory. [Cited 22 Aug 2006]. Available from: http:// jaxmice.jax.org/list/ ra82.html.
27. Hedner U, Ginsburg D, Lusher JM, High KA. 2000. Congenital hemorrhagic disorders: new insights into the pathophysiology and treatment of hemophilia. Hematology Am Soc Hematol Educ Program 241-265.
28. Hoffman M. 2003. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 17 Suppl 1:S1-S5.
29. Hogan WJ, McBane RD, Santrach PJ, Plumhoff EA, Oliver WC, Jr., Schaff HV, Rodeheffer RJ, Edwards WD, Duffy J, Nichols WL. 2000. Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc 75:971-976.
30. Isordia-Salas I, Pixley RA, Li F, Sainz I, Sartor RB, Adam A, Colman RW. 2002. Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats. Am J Physiol Gastrointest Liver Physiol 283:G180-G186.
31. Isordia-Salas I, Pixley RA, Sainz IM, Martinez-Murillo C, Colman RW. 2004. The role of plasma high molecular-weight kininogen in experimental intestinal and systemic inflammation. Arch Med Res 35:369-377.
32. Isordia-Salas I, Pixley RA, Sainz IM, Martinez-Murillo C, Colman RW. 2005. The role of plasma high molecular-weight kininogen in experimental intestinal and systemic inflammation. Arch Med Res 36:87-95.
33. Joseph K, Kaplan AP. 2005. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 86:159-208.
34. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, Fratantoni J, Green D, Hampton J, Hilgartner M, Levine P, Lazerson J, McMillan C, Penner J, Shapiro S, Shulman NR. 1975. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 34:612.
35. Kornprat P, Bacher H, Cerwenka H, El Shabrawi A, Langner C, Mischinger HJ. 2005. Intestinal bleeding associated with antiphospholipid antibody syndrome. Endoscopy 37:95.
36. Lillicrap D. 1998. The molecular basis of haemophilia B. Haemophilia 4:350-357.
37. Lindsey JW. 1996. Characteristics of initial and reinduced experimental autoimmune encephalomyelitis. Immunogenetics 44:292-297.
38. McIntyre JA, Wagenknecht DR, Faulk WP. 2003. Antiphospholipid antibodies: discovery, definitions, detection and disease. Prog Lipid Res 42:176-237.
39. McIntyre JA, Wagenknecht DR, Waxman DW. 2003. Frequency and specificities of antiphospholipid antibodies (aPL) in volunteer blood donors. Immunobiology 207:59-63.
40. Meier H, Allen RC, Hoag WG. 1962. Spontaneous hemorrhagic diathesis in inbred mice due to single or multiple "prothrombin-complex" deficiencies. Blood 19:501-514.
41. Meier H, Hoag WG. 1966. Blood coagulation. In: Green EL, editor. Biology of the laboratory mouse. New York (NY): McGraw-Hill.
42. Mitchell M, Keeney S, Goodeve A. 2005. The molecular analysis of haemophilia B: a guideline from the UK haemophilia centre doctors' organization haemophilia genetics laboratory network. Haemophilia 11:398-404.
43. Peters LL, Cheever EM, Ellis HR, Magnani PA, Svenson KL, Von Smith R, Bogue MA [Internet]. Mouse phenome database. Bar Harbor (ME): Jackson Laboratories. [cited 2006 April 10]. Available from http://www.jax.org/phenome.
44. Rodriguez V, Reed AM, Kuntz NL, Anderson PM, Smithson WA, Nichols WL. 2005. Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus. J Pediatr Hematol Oncol 27:403-407.
45. Sainz IM, Isordia-Salas I, Castaneda JL, Agelan A, Liu B, DeLa Cadena RA, Pixley RA, Adam A, Sartor RB, Colman RW. 2005. Modulation of inflammation by kininogen deficiency in a rat model of inflammatory arthritis. Arthritis Rheum 52:2549-2552.
46. Sarkar G, Koeberl DD, Sommer SS. 1990. Direct sequencing of the activation peptide and the catalytic domain of the factor IX gene in six species. Genomics 6:133-143.
47. Saxena R, Gupta PK, Ahmed R, Batra V, Kumar S. 2003. D-dimer test: diagnostic role in clinical and sub-clinical DIC. Indian J Pathol Microbiol 46:425-426.
48. Sommer SS, Ketterling RP. 1996. The factor IX gene as a model for analysis of human germline mutations: an update. Hum Mol Genet 5 Spec No:1505-1514.
49. Toth LA. 1996. Strain differences in the somnogenic effects of interferon inducers in mice. J Interferon Cytokine Res 16:1065-1072.
50. Toth LA. 2001. Increased slow-wave sleep during concanavalin-A-induced hepatitis in mice. Brain Behav Immun 15:190-191.
51. Toth LA, Hughes LF. 2004. Macrophage participation in influenza-induced sleep enhancement in C57BL/6J mice. Brain Behav Immun 18:375-389.
52. Toth LA, Hughes LF. 2005. Sleep and activity during concanavalin-A- induced hepatitis in inbred mice. Sleep 28:571-585.
53. Toth LA, Lyons S, Cox L. 2003. Sleep patterns during Candida albicans-induced renal disease in mice. Sleep 26:A365.
54. Toth LA, Verhulst SJ. 2003. Strain differences in sleep patterns of healthy and influenza-infected inbred mice. Behav Genet 33:325-336.
55. Triplett DA. 2000. Coagulation and bleeding disorders: review and update. Clin Chem 46:1260-1269.
56. Triplett D, Harms C. 1981. Factor assays. In: Triplett DA, editor. Procedures for the coagulation laboratory. Chicago: American Society of Clinical Pathologists Press. p 38-57.
57. Ueno A, Oh-ishi S. 2003. Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats. J Pharmacol Sci 93:1-20.
58. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. 2001. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 85:560.
59. Wu SM, Stafford DW, Ware J. 1990. Deduced amino acid sequence of mouse blood-coagulation factor IX. Gene 86:275-278.
60. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. 1985. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 24:3736-3750.